New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 22, 2013
08:35 EDTLPTNLpath granted U.S., European patents related to ASONEP
Lpath received official notification from the European Patent Office, or EPO, and the U.S. Patent and Trademark Office, or USPTO, that the company has been issued three key patents. The patents cover methods of detecting sphingolipid levels, as well as covering monoclonal antibodies, including ASONEP and iSONEP, that bind to and neutralize sphingosine-1-phosphate.
News For LPTN From The Last 14 Days
Check below for free stories on LPTN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for LPTN

Sign up for a free trial to see the rest of the stories you've been missing.